← Other lipid agents × lipids

SynthesisEndocrine2023

Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis.

Rene Rodriguez-Gutierrez et al.PubMed ↗Publisher ↗

What the trial testedas reported · 2023

Range includes no effect

No clear effect on lipids

−1%−24% to +9%

Smaller than almost all on the map

As reported

RR 0.99, 95% CI 0.76–1.09

One number in the abstract

the abstract, start to end

… when compared to statin therapy (RR 0.99, CI 0.76 to 1.09).

← favours treatmentfavours comparator →
could be chance
Lipids
RR 0.990.76–1.09
Other lipid agentsLipids
1 / 3

9 papers cite it

2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37247046